PCR Technologies Market

The report "PCR Technologies Market by Technology (qPCR, dPCR, Multiplex, RT-PCR), Product (Instruments, Reagents & Consumables, Software), Application (Genotyping, Diagnostics, Environmental), End User (Hospital, Academia, Pharma-Biopharma) – Global forecast to 2031", PCR technologies market to reach USD 21.43 billion by 2031 from USD 15.55 billion in 2026, at a CAGR of 6.6% during 2026–2031. The primary drivers of the PCR technologies market are the growing demand for rapid, accurate, and sensitive nucleic acid detection across clinical diagnostics, genomics, biotechnology, and pharmaceutical research. Expanding applications in infectious disease testing, oncology, genetic analysis, and personalized medicine, along with advances in real-time PCR, digital PCR, multiplex PCR, and automated platforms, are improving testing efficiency and broadening PCR adoption. Rising investments in molecular diagnostics, genomics research, laboratory infrastructure, and point-of-care testing are further supporting market growth.

Browse 350 market data Tables and 200 Figures spread through 350 Pages and in-depth TOC on"PCR Technologies Market by Technology (qPCR, dPCR, Multiplex, RT-PCR), Product (Instruments, Reagents & Consumables, Software), Application (Genotyping, Diagnostics, Environmental), End User (Hospital, Academia, Pharma-Biopharma) – Global forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/pcr-technologies-market-96291811.html

Reagents and consumables dominated market in 2025.

Reagents and consumables are essential to efficient PCR workflows and include primers, buffers, nucleotides, polymerases, PCR and microcentrifuge tubes, pipette tips, and sealing materials. Their recurring use and frequent replenishment contribute to the segment’s leading market position. Growing applications in genetic research, cancer diagnostics, infectious disease testing, and personalized medicine are further increasing demand, particularly for advanced reagents that support real-time PCR, digital PCR, and RT-qPCR.

Diagnostic applications accounted for the largest market share of 2025.

Due to its high sensitivity and specificity in diagnosing various infections, genetic disorders, and cancer markers, PCR holds the largest share of the diagnostics market. Because it can detect even a minute number of pathogens in a human patient, it has emerged as a diagnostic tool for determining bacterial and viral infections such as hepatitis, HIV, COVID-19, and tuberculosis. Additionally, increasing trends in prenatal diagnostics, personalized medicine, and genetic screening enhance its application. Ongoing developments in PCR technologies, including real-time PCR and point-of-care testing, further support the growth of this market.

Diagnostic laboratories remain the largest in 2025.

Diagnostic laboratories are expected to remain the largest end users of PCR technologies in 2025, driven by the growing need for rapid, accurate molecular testing. PCR is widely used to detect infectious diseases, cancer and oncology biomarkers, genetic conditions, and other clinical conditions. High testing volumes, repeat testing requirements, and the increasing adoption of advanced molecular diagnostic workflows continue to support strong PCR utilization across diagnostic laboratories.

Major Market Players in PCR Technologies

In the PCR technologies market, the following players hold the largest market shares. They are: F. Hoffman-La Roche Ltd. (Switzerland); Thermo Fisher Scientific, Inc. (US); Bio-Rad Laboratories, Inc. (US); QIAGEN (Germany); Takara Bio, Inc. (Japan); Agilent Technologies, Inc. (US); Standard Biotools (US); Lonza (Switzerland); Danaher Corporation (US); Abbott Laboratories (US); Merck KGaA (Germany); Bioneer Corporation (South Korea); Hologic Inc. (US); Sansure Biotech Inc. (China); Becton, Dickinson and Company (US); and Analytik Jena AG (Germany), among others.

Don’t miss out on business opportunities in PCR Technologies Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com